Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged ptab · clear
Written by Diana E. Wade and Bridget A. Smith The Federal Circuit held that the PTAB may consider legal conclusions of obviousness by experts, but the expert papers must make adequate factual findings and provide a satisfactory explanation as to…
Written by Scott Raevsky and David T. Kim In a final written decision, the Board denied a patent owner’s request for a certificate of correction filed shortly after IPR institution in Douglas Dynamics, L.L.C. v. Meyer Products, LLC, IPR2015-01839,…
The last few weeks, our Data Science Team analyzed the most active petitioners in Inter-Partes Review (IPR) cases. Now we have turned our attention towards the patent owners in IPR cases. Our analysis shows that since IPR’s inception in 2012 through…
Written by Kerry S. Taylor, Ph.D. and Nathanael Luman, Ph.D. The PTAB issued a Final Written Decision upholding Pozen’s ulcer reducing Vimovo® claims based on unexpected results in Coalition For Affordable Drugs VII LLC v. Pozen Inc.,…
In Secure Access, LLC v. PNC BANK NATIONAL ASSOCIATION, [2016-1353] (February 21, 2017), the Federal Circuit vacated the Board’s decision in CBM2014-00100 on the ground that U.S. Patent No. 7,631,191 on a "system and method for authenticating a…
This week, our Data Science Team continued reviewing Apple’s IPR cases with a focus on patent owners. We wanted to learn which entities had their patents challenged by Apple since the inception of Inter-Partes Review in 2012. We’ve unveiled the…
Written by Hyeongsu Rick Park and Kerry S. Taylor, Ph.D. The Patent Trial and Appeal Board (PTAB) terminated a patent interference proceeding between the University of California (UC) and the Broad Institute (Broad), a joint venture of Harvard University…
Written by Peter Heuser, Schwabe Williamson & Wyatt In Metalcraft , the Circuit affirms a preliminary injunction based largely on the patentee’s proof that it ‎would be impossible to quantify damages ‎caused by loss of potentially-lifelong…
Yesterday, the PTAB in interference 106,048 issued a short order finding no interference- in- fact between the claims of 12 Broad Institute patents (US Patent Number 8,697,359 et al.) and the application held by The Regents of the University of California…
The admissibility of evidence is an important consideration for many PTAB proceedings. The procedures for objecting to and admitting evidence can be nuanced and, as often is the case with the PTAB, the devil is in the details. Panels are also quick to…
This week, Patexia Data Science Team continued reviewing Apple’s IPR challenges. However, we turned our attention towards PTAB Panel of Administrative Judges. Given that Apple has been the most active company responsible for filing almost 5 percent…
Last month, the Federal Circuit made clear that Article III standing is necessary for petitioners to appeal from adverse decisions in AIA trial proceedings in Phigenix, Inc. v. ImmunoGen, Inc. ( here ) The Phigenix decision follows an earlier decision ,…
